Clinical Trial Update: Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leukemia

View source ↗

Summary

Clinical trial NCT01069432, a protocol to obtain blood for discovery of biomarkers and potential therapeutic targets in chronic lymphocytic leukemia, has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Chronic Lymphocytic Leukemia | Status: WITHDRAWN